Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) E10: ¥0.81 (As of Mar. 2026)


SHSE:600276 Jiangsu Hengrui Pharmaceuticals Co Ltd SHSE:600276
92 GF Score
Price ¥53.78
GF Value ¥60.44
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jiangsu Hengrui Pharmaceuticals Co E10?

Jiangsu Hengrui Pharmaceuticals Co SHSE:600276 +3.34% 92 E10 is ¥0.81 as of Mar. 2026. GuruFocus rates SHSE:600276 with a GF Score™ of 92/100 and a GF Value™ of ¥60.44 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jiangsu Hengrui Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.340. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.81 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jiangsu Hengrui Pharmaceuticals Co's average E10 Growth Rate was 12.50% per year. During the past 3 years, the average E10 Growth Rate was 10.20% per year. During the past 5 years, the average E10 Growth Rate was 10.00% per year. During the past 10 years, the average E10 Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jiangsu Hengrui Pharmaceuticals Co was 26.00% per year. The lowest was 9.00% per year. And the median was 24.30% per year.

As of today (2026-07-01), Jiangsu Hengrui Pharmaceuticals Co's current stock price is ¥53.78. Jiangsu Hengrui Pharmaceuticals Co's E10 for the quarter that ended in Mar. 2026 was ¥0.81. Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio of today is 66.40.

During the past 13 years, the highest Shiller PE Ratio of Jiangsu Hengrui Pharmaceuticals Co was 212.98. The lowest was 52.39. And the median was 91.75.


Jiangsu Hengrui Pharmaceuticals Co  (SHSE:600276) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jiangsu Hengrui Pharmaceuticals Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=53.78/0.81
=66.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jiangsu Hengrui Pharmaceuticals Co was 212.98. The lowest was 52.39. And the median was 91.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jiangsu Hengrui Pharmaceuticals Co E10 Related Terms


Jiangsu Hengrui Pharmaceuticals Co E10 Historical Data

* Premium members only.

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Hengrui Pharmaceuticals Co E10 Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.59 0.63 0.70 0.79

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.75 0.77 0.79 0.81

SHSE:600276 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Hengrui Pharmaceuticals Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio falls into.


SHSE:600276
92GF Score
Jiangsu Hengrui Pharmaceuticals Co Ltd SHSE:600276
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Hengrui Pharmaceuticals Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Hengrui Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.34/116.3033*116.3033
=0.340

Current CPI (Mar. 2026) = 116.3033.

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.099 101.400 0.114
201609 0.098 102.400 0.111
201612 0.107 102.600 0.121
201703 0.129 103.200 0.145
201706 0.120 103.100 0.135
201709 0.122 104.100 0.136
201712 0.133 104.500 0.148
201803 0.146 105.300 0.161
201806 0.153 104.900 0.170
201809 0.160 106.600 0.175
201812 0.181 106.500 0.198
201903 0.188 107.700 0.203
201906 0.188 107.700 0.203
201909 0.208 109.800 0.220
201912 0.250 111.200 0.261
202003 0.207 112.300 0.214
202006 0.211 110.400 0.222
202009 0.250 111.700 0.260
202012 0.320 111.500 0.334
202103 0.230 112.662 0.237
202106 0.190 111.769 0.198
202109 0.240 112.215 0.249
202112 0.050 113.108 0.051
202203 0.190 114.335 0.193
202206 0.140 114.558 0.142
202209 0.170 115.339 0.171
202212 0.110 115.116 0.111
202303 0.190 115.116 0.192
202306 0.170 114.558 0.173
202309 0.190 115.339 0.192
202312 0.130 114.781 0.132
202403 0.210 115.227 0.212
202406 0.330 114.781 0.334
202409 0.190 115.785 0.191
202412 0.270 114.893 0.273
202503 0.300 115.116 0.303
202506 0.400 114.907 0.405
202509 0.190 115.471 0.191
202512 0.290 115.832 0.291
202603 0.340 116.303 0.340

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.81 mean?
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) has a E10 of ¥0.81 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors.
Is Jiangsu Hengrui Pharmaceuticals Co's E10 too high?
Jiangsu Hengrui Pharmaceuticals Co's current E10 is ¥0.81. Overall, Jiangsu Hengrui Pharmaceuticals Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Hengrui Pharmaceuticals Co's E10 compare to ZTS and UTHR?
Jiangsu Hengrui Pharmaceuticals Co's E10 of ¥0.81 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors. Jiangsu Hengrui Pharmaceuticals Co's current E10 is ¥0.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Hengrui Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥60.44, compared to a current price of ¥53.78 — trading 11% below its estimated fair value. The current E10 is ¥0.81. Jiangsu Hengrui Pharmaceuticals Co's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276), the current E10 is ¥0.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co stock appears to be undervalued. The current stock price of ¥53.78 is trading 11% below its estimated GF Value™ of ¥60.44. GuruFocus considers Jiangsu Hengrui Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for SHSE:600276:

  • E10: ¥0.81
  • GF Value™: ¥60.44 vs. price of ¥53.78 (11% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Hengrui Pharmaceuticals Co Business Description

Address No. 7, Kunlunshan Road, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222000
Jiangsu Hengrui Pharmaceuticals Co Ltd is a biopharmaceutical company that engages in the research, development, manufacture, and sale of drugs. It is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs, and anti-infection medications. The company specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system. Geographically, the company is segmented as Chinese mainland and Other countries generating majority revenue from the Chinese region.
92GF Score

Get the complete analysis for SHSE:600276

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥53.78
Price
¥60.44
GF Value